Scott H Olejniczak

13PUBLICATIONS
48CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsBiological adaptationMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 16, 2026
Interleukin-18 armours antitumour immune effectors.

|May 20, 2026
Immunological consequences of chemotherapy: implications for cancer immunotherapy.

|Feb 02, 2026
Endogenous CD28 Drives the Persistent Activity of CAR T Cells in Myeloma and Lymphoma Models.

Mackenzie M Lieberman, Jason H Tong, Nkechi U Odukwe

|Sep 24, 2025
Second signals for cancer immunotherapy.

Scott H Olejniczak, Michael T Lotze, Dimitris Skokos

|Jul 14, 2025
p38 blockade reverses the immune suppressive tumor microenvironment in metastatic breast cancer.

Priyanka Rajan, Robert Zollo, Yanqi Guo

|Jul 25, 2024
CD28 co-stimulation: novel insights and applications in cancer immunotherapy.

Michael T Lotze, Scott H Olejniczak, Dimitris Skokos

Pageof 3

Frequent Collaborators

4 joint publications

Mackenzie M Lieberman

2 joint publications

Bowen Dong

2 joint publications

Nataša Obermajer

2 joint publications

Jason H Tong